Blocking CX3CL1 can effectively diminish the infiltration of alloreactive CD8+T cells in the intestine and alleviate the apoptosis of intestinal crypt cells, providing a new strategy for the treatment of intestinal damage in acute GVHD (101). The gene discussed is CX3CL1; the disease is acute graft versus host disease.